Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Marissa Bothun

Physician Assistant Rockwall, TX Physician Assistant

NPI 1942507207 CMS profile 10609572

1020 W Ralph Hall Pkwy Ste 102, Rockwall, TX 75032

Open in the dashboard

General payments

$13,682

706 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Marissa Bothun of Rockwall, TX is reported in the CMS Open Payments database as having received $13,682 across 706 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,015 150
2024 General $3,289 159
2023 General $2,721 145
2022 General $2,468 127
2021 General $2,190 125

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Marissa Bothun
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Marissa Bothun were reported at $3,015. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Marissa Bothun Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $2,190 $132 $37–$438 $132
2022 $2,468 $155 $48–$522 $149
2023 $2,721 $167 $52–$557 $160
2024 $3,289 $178 $55–$600 $164
2025 $3,015 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Janssen Biotech, Inc. $2,155 101 payments
  2. Sun Pharmaceutical Industries Inc. $1,897 92 payments
  3. AbbVie, Inc. $1,361 71 payments
  4. Regeneron Healthcare Solutions, Inc. $1,360 58 payments
  5. Genzyme Corporation $682 37 payments
  6. Galderma Laboratories, L.P. $610 41 payments
  7. UCB, Inc. $547 22 payments
  8. Arcutis Biotherapeutics, Inc. $534 51 payments
  9. E.R. Squibb & Sons, L.L.C. $506 33 payments
  10. Lilly USA, LLC $442 20 payments
  11. Other $3,589 180 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $12,640 689 payments
  2. Education $1,019 16 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $23 1 payment
Products named General payments · program years 2021–2025
  1. TREMFYA $2,019 94 payments
  2. DUPIXENT Immunology $1,017 46 payments
  3. DUPIXENT Inflammation And Immunology $900 39 payments
  4. SKYRIZI $862 40 payments
  5. Winlevi $855 55 payments
  6. ILUMYA $583 25 payments
  7. SOTYKTU $473 31 payments
  8. Bimzelx $442 17 payments
  9. ZILXI $407 28 payments
  10. ADBRY $376 16 payments
  11. Other $8,353 407 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

910

Median for Physician Assistant: 241

Drug cost

$177,104

Median for Physician Assistant: $4,110

Branded share of claims

6%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Humira(Cf) Adalimumab Brand 14 $112,429
Dupixent Pen Dupilumab Brand 11 $43,090
Clobetasol Propionate Generic 125 $4,715
Betamethasone Dipropionate Generic 75 $3,431
Fluorouracil Generic 48 $3,138
Ketoconazole Generic 203 $2,504
Metronidazole Generic 45 $1,912
Triamcinolone Acetonide Generic 169 $1,802
Clindamycin Phosphate Generic 39 $1,305
Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip Brand 30 $712

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$167,366

Medicare's payments for the services billed

Medicare patients

803

Average age 75

Services billed

5,286

444 women, 359 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 69%
Arthritis 46%
Ischemic heart disease 24%
Diabetes 22%
Chronic kidney disease 21%
Depression 17%
Atrial fibrillation 14%
Cancer 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 29 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DUPIXENT
  • Regeneron Healthcare Solutions, Inc. $369
  • GENZYME CORPORATION $132
$500 11 —
TREMFYA
  • Janssen Biotech, Inc. $421
$421 — —
SKYRIZI
  • AbbVie, Inc. $349
$349 — —
Winlevi
  • Sun Pharmaceutical Industries Inc. $346
$346 — —
Zoryve
  • Arcutis Biotherapeutics, Inc. $199
$199 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 29 with Patron

Records

706 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record